Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19387705 | 0.83 | KDM4E (0.36) | HTTCYP2C19MEN1KMT2AGLA | |
| SCHEMBL24673657 | 0.81 | KDM4E (0.38) | HTTCYP2C19MEN1KMT2AGLA | |
| SCHEMBL18773530 | 0.81 | KDM4E (0.38) | HTTCYP2C19MEN1KMT2AGLA | |
| SCHEMBL19749146 | 0.81 | KDM4E (0.38) | HTTCYP2C19MEN1KMT2AGLA | |
| SCHEMBL23787476 | 0.80 | KDM4E (0.37) | CYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL22546863 | 0.80 | CYP2C19 (0.39) | CYP2C19MEN1KMT2AGLACYP1A2 | |
| SCHEMBL6236876 | 0.79 | CYP2C19 (0.47) | HTTCYP2C19MEN1KMT2AGLA | |
| SCHEMBL20671219 | 0.78 | KDM4E (0.33) | — | |
| SCHEMBL22861730 | 0.78 | TSHR (0.40) | HTTMEN1KMT2ATSHR | |
| SCHEMBL25560014 | 0.78 | KDM4E (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9738631-B2 | Compositions and methods for the treatment of neurological disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2017-08-22 | — | — | US | disclosed |